1. 992 RESULTS OF A PILOT HIV/FRAILTY CLINIC - CAN COMPREHENSIVE GERIATRIC ASSESSMENT BENEFIT FRAIL PEOPLE LIVING WITH HIV?. (14th June 2022) Authors: Morrow, H; Horner, M; Thomson-Glover, R Journal: Age and ageing Issue: Volume 51(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A-13 Demographic Differences in Performance Validity Test Failures. (28th August 2020) Authors: Braun, S; Fountain-Zaragoza, S; Halliday, C; Horner, M Journal: Archives of clinical neuropsychology Issue: Volume 35:Number 6(2020) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P65 Failure to control hepatitis B virus replication despite control of human immunodeficiency virus replication in co-infected patients on tenofovir-containing ART regimen cause for concern in hepatitis B virus monoinfection?. (16th November 2010) Authors: Joshi, D; Childs, K; Carey, I; Bruce, M; Al-Freah, M; Horner, M; Harrison, P; Suddle, A; Agarwal, K; Taylor, C Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P66 Low pre-treatment plasma HBsAg level and its decline during add-on interferon treatment predict response to combined lamivudine/interferon therapy in tolerant children with infancy-acquired chronic hepatitis B. (6th September 2011) Authors: Carey, I; Horner, M; Bruce, M; Bansal, S; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P69 Hepatitis delta RNA level and genotype, and hepatitis B surface antigen titre predict response to PEG-interferon in the treatment of chronic hepatitis delta virus. (16th November 2010) Authors: Hughes, S; Carey, I; Shang, D; Horner, M; Bruce, M; Fletcher, I; Cross, T J S; Suddle, A; Agarwal, K; Harrison, P M Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PMO-154 Plasma HBSAG levels decline was similar during subsequent pegylated interferon and nucleos(T)IDE analogues treatment in chronic hepatitis B patients. (28th May 2012) Authors: Bruce, M J; Horner, M; Hughes, S; Knighton, S; Joshi, D; Harrison, P M; Agarwal, K; Carey, I Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B. (28th May 2012) Authors: Carey, I; Bruce, M J; Hussain, M; Horner, M; Bansal, S; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PMO-156 Plasma HBsAG levels correlate with liver cccDNA in tolerant children with infancy acquired chronic hepatitis B infection. (28th May 2012) Authors: Carey, I; Zen, Y; Bruce, M J; Horner, M; Bansal, S; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PMO-157 HBSAG plasma levels decline helps to predict HBEAG loss but is similar in different NUCLEOS(T)IDE analogues regimens. (28th May 2012) Authors: Horner, M; Bruce, M J; Knighton, S; Al-Freah, M; Joshi, D; Hughes, S; Suddle, A; Harrison, P M; Agarwal, K; Carey, I Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PMO-178 The significance of viral and serological markers in predicting liver disease severity in e-Ag negative hepatitis b virus infection. (28th May 2012) Authors: Audimoolam, V K; Carey, I; Bruce, M; Horner, M; Abid, S; Agarwal, K; Harrison, P Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗